Literature DB >> 8393294

Renal tubular Na(+)-K(+)-ATPase in diabetes mellitus: relationship to metabolic abnormality.

H Wald1, P Scherzer, R Rasch, M M Popovtzer.   

Abstract

This study was undertaken to evaluate the effect of long-term diabetes on Na(+)-K(+)-ATPase in isolated nephron segments in five groups of rats: 1) controls of 7 wk duration (7 WD), 2) diabetes mellitus (DM) of 7 WD, 3) DM of 7 WD treated with insulin replacement, 4) DM rats of 25 WD, and 5) control rats of 25 WD. The blood glucose (BG) values in the first three groups were 123 +/- 9, 450 +/- 25, and 302 +/- 30 mg/dl; the glomerular filtration rate (GFR) was 1.34 +/- 0.08, 1.80 +/- 0.10, and 1.77 +/- 0.08 ml/min; and urinary sodium excretion was 0.94 +/- 0.05, 1.76 +/- 0.10, and 1.40 +/- 0.07 mu eq/min. Na(+)-K(+)-ATPase in group 2 increased in all segments studied (P < 0.001, group 1 vs. 2 for all). In group 3, Na(+)-K(+)-ATPase normalized in proximal convoluted (PC), proximal straight (PS), and distal convoluted (DC) tubules (P < 0.001, group 2 vs. group 3 for all), whereas in the outer medullary thick ascending limb (OMTAL) the correction was partial and in the CTAL and CCD there was no correction. In group 4 BG was 420 +/- 20 mg/100 ml compared with 123 +/- 9 in group 5 (P < 0.001), and GFR was 1.19 +/- 0.11 ml/min vs. 1.15 +/- 0.11 in group 5 (P = not significant).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393294     DOI: 10.1152/ajpendo.1993.265.1.E96

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Regulation of type II transforming-growth-factor-beta receptors by protein kinase C iota.

Authors:  Lea-Yea Chuang; Jinn-Yuh Guh; Shu-Fen Liu; Min-Yuan Hung; Tung-Nan Liao; Tai-An Chiang; Jau-Shyang Huang; Yu-Lun Huang; Chi-Fong Lin; Yu-Lin Yang
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

2.  NADPH oxidase and PKC contribute to increased Na transport by the thick ascending limb during type 1 diabetes.

Authors:  Jing Yang; Jennifer S Pollock; Pamela K Carmines
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

3.  C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells.

Authors:  Z Zhong; A Davidescu; I Ehrén; K Ekberg; H Jörnvall; J Wahren; A V Chibalin
Journal:  Diabetologia       Date:  2004-12-29       Impact factor: 10.122

4.  Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin.

Authors:  Yu-Lin Yang; Lea-Yea Chuang; Jinn-Yuh Guh; Shu-Fen Liu; Min-Yuan Hung; Tung-Nan Liao; Yu-Lun Huang
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

5.  Effect of myo-inositol supplementation on the development of renal pathological changes in the Cohen diabetic (type 2) rat.

Authors:  A M Cohen; H Wald; M Popovtzer; E Rosenmann
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

6.  C-peptide stimulates rat renal tubular Na+, K(+)-ATPase activity in synergism with neuropeptide Y.

Authors:  Y Ohtomo; A Aperia; B Sahlgren; B L Johansson; J Wahren
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

7.  Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption.

Authors:  Lina Nordquist; Russell Brown; Angelica Fasching; Patrik Persson; Fredrik Palm
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-09

8.  Interaction between NO synthase and NADPH oxidase in control of sodium transport by the renal thick ascending limb during diabetes.

Authors:  C De Miguel; J M Foster; P K Carmines; J S Pollock
Journal:  Acta Physiol (Oxf)       Date:  2013-07-25       Impact factor: 6.311

9.  C-Peptide and its intracellular signaling.

Authors:  Claire E Hills; Nigel J Brunskill
Journal:  Rev Diabet Stud       Date:  2009-11-10

10.  C-Peptide: the missing link in diabetic nephropathy?

Authors:  Lina Nordquist; John Wahren
Journal:  Rev Diabet Stud       Date:  2009-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.